Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Roberto R Rosato & Steven Grant. (2004) Histone deacetylase inhibitors in clinical development. Expert Opinion on Investigational Drugs 13:1, pages 21-38.
Read now
Read now
William K Kelly, Owen A O’Connor & Paul A Marks. (2002) Histone deacetylase inhibitors: from target to clinical trials. Expert Opinion on Investigational Drugs 11:12, pages 1695-1713.
Read now
Read now
Articles from other publishers (19)
Cesar A. Perez, Edgardo S. Santos, Belisario A. Arango, Luis E. Raez & Ezra E. W. Cohen. (2011) Novel molecular targeted therapies for refractory thyroid cancer. Head & Neck 34:5, pages 736-745.
Crossref
Crossref
Jingli Hou, Congran Feng, Zhonghua Li, Qinghong Fang, Huihui Wang, Guoxian Gu, Yikang Shi, Pi Liu, Feng Xu, Zheng Yin, Jie Shen & Peng Wang. (2011) Structure-based optimization of click-based histone deacetylase inhibitors. European Journal of Medicinal Chemistry 46:8, pages 3190-3200.
Crossref
Crossref
Camille N. Abboud. 2011. Adult Acute Lymphocytic Leukemia. Adult Acute Lymphocytic Leukemia
257
275
.
Nurul M. Islam, Tamaki Kato, Norikazu Nishino, Hyun-Jung Kim, Akihiro Ito & Minoru Yoshida. (2010) Bicyclic peptides as potent inhibitors of histone deacetylases: Optimization of alkyl loop length. Bioorganic & Medicinal Chemistry Letters 20:3, pages 997-999.
Crossref
Crossref
Rino Ragno, Silvia Simeoni, Dante Rotili, Antonella Caroli, Giorgia Botta, Gerald Brosch, Silvio Massa & Antonello Mai. (2008) Class II-selective histone deacetylase inhibitors. Part 2: Alignment-independent GRIND 3-D QSAR, homology and docking studies. European Journal of Medicinal Chemistry 43:3, pages 621-632.
Crossref
Crossref
Norikazu Nishino, Gururaj M. Shivashimpi, Preeti B. Soni, Mohammed P.I. Bhuiyan, Tamaki Kato, Satoko Maeda, Tomonori G. Nishino & Minoru Yoshida. (2008) Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides. Bioorganic & Medicinal Chemistry 16:1, pages 437-445.
Crossref
Crossref
Gururaj M. Shivashimpi, Satoshi Amagai, Tamaki Kato, Norikazu Nishino, Satoko Maeda, Tomonori G. Nishino & Minoru Yoshida. (2007) Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework. Bioorganic & Medicinal Chemistry 15:24, pages 7830-7839.
Crossref
Crossref
Christopher L. Hamblett, Joey L. Methot, Dawn M. Mampreian, David L. Sloman, Matthew G. Stanton, Astrid M. Kral, Judith C. Fleming, Jonathan C. Cruz, Melissa Chenard, Nicole Ozerova, Anna M. Hitz, Hongmei Wang, Sujal V. Deshmukh, Naim Nazef, Andreas Harsch, Bethany Hughes, William K. Dahlberg, Alex A. Szewczak, Richard E. Middleton, Ralph T. Mosley, J. Paul Secrist & Thomas A. Miller. (2007) The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters 17:19, pages 5300-5309.
Crossref
Crossref
Antonello Mai, Dante Rotili, Silvio Massa, Gerald Brosch, Giovanna Simonetti, Claudio Passariello & Anna Teresa Palamara. (2007) Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans. Bioorganic & Medicinal Chemistry Letters 17:5, pages 1221-1225.
Crossref
Crossref
Mohammed P.I. Bhuiyan, Tamaki Kato, Tatsuo Okauchi, Norikazu Nishino, Satoko Maeda, Tomonori G. Nishino & Minoru Yoshida. (2006) Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases. Bioorganic & Medicinal Chemistry 14:10, pages 3438-3446.
Crossref
Crossref
Antonello Mai, Silvio Massa, Sergio Valente, Silvia Simeoni, Rino Ragno, Patrizia Bottoni, Roberto Scatena & Gerald Brosch. (2006) Aroyl-Pyrrolyl Hydroxyamides: Influence of Pyrrole C4-Phenylacetyl Substitution on Histone Deacetylase Inhibition. ChemMedChem 1:2, pages 225-237.
Crossref
Crossref
Constantine S. Mitsiades, Vassiliki Poulaki, Ciaran McMullan, Joseph Negri, Galinos Fanourakis, Athina Goudopoulou, Victoria M. Richon, Paul A. Marks & Nicholas Mitsiades. (2005) Novel Histone Deacetylase Inhibitors in the Treatment of Thyroid Cancer. Clinical Cancer Research 11:10, pages 3958-3965.
Crossref
Crossref
Antonello Mai, Silvio Massa, Dante Rotili, Ilaria Cerbara, Sergio Valente, Riccardo Pezzi, Silvia Simeoni & Rino Ragno. (2005) Histone deacetylation in epigenetics: An attractive target for anticancer therapy. Medicinal Research Reviews 25:3, pages 261-309.
Crossref
Crossref
Kapil Bhalla & Alan List. (2004) Histone deacetylase inhibitors in myelodysplastic syndrome. Best Practice & Research Clinical Haematology 17:4, pages 595-611.
Crossref
Crossref
Nicholas MitsiadesConstantine S. MitsiadesPaul G. RichardsonCiaran McMullanVassiliki PoulakiGalinos FanourakisRobert SchlossmanDharminder ChauhanNikhil C. MunshiTeru HideshimaVictoria M. RichonPaul A. MarksKenneth C. Anderson. (2003) Molecular sequelae of histone deacetylase inhibition in human malignant B cells. Blood 101:10, pages 4055-4062.
Crossref
Crossref
Fyodor D. Urnov & Alan P. Wolffe. 2002. Wiley Encyclopedia of Molecular Medicine. Wiley Encyclopedia of Molecular Medicine.
Paul A. Marks, Richard A. Rifkind, Victoria M. Richon, Ronald Breslow, Thomas Miller & William K. Kelly. (2001) Histone deacetylases and cancer: causes and therapies. Nature Reviews Cancer 1:3, pages 194-202.
Crossref
Crossref
Paul A. Marks, Victoria M. Richon, Ronald Breslow & Richard A. Rifkind. (2001) Histone deacetylase inhibitors as new cancer drugs. Current Opinion in Oncology 13:6, pages 477-483.
Crossref
Crossref
Stefano Guandalini & Ranjana Gokhale. (2001) Update on immunologic basis of celiac disease. Current Opinion in Gastroenterology 17:6, pages 545-550.
Crossref
Crossref